Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
518.00    -2.00 (-0.38%)
Bid:
516.00
Ask:
520.00
Spread: 4.00 (0.775%)
Market Cap: £857.11m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Director Dealing

3 Feb 2025 07:00

RNS Number : 5194V
Oakley Capital Investments Limited
03 February 2025
 

3 February 2025

 

Oakley Capital Investments Limited

 

Director Dealing

 

Oakley Capital Investments Limited1 (the "Company"), was notified today of the following transaction by a Director of the Company:

Steve Pearce, a Director of the Company, has purchased 18,757 Ordinary Shares in the Company ("Ordinary Shares") at an aggregate price of 487.43 pence per share. As a result, Mr Pearce is now interested in 18,757 Ordinary Shares of the Company, representing 0.01% percent of the issued share capital.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Steve Pearce

2

Reason for the notification

 

a)

Position/status

 

Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Oakley Capital Investments Limited

b)

LEI

 

213800KW6MZUK12CQ815

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 1p each

 

 

 

 

 

BMG670131058

b)

Nature of the transaction

 

Acquisition

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

488p

485.5p

 

14,475

4,282

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

18,757

 

 

487.43p

e)

Date of the transaction

 

30 January 2025

f)

Place of the transaction

 

London Stock Exchange, Specialist Fund Segment

 

 

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget

 

Greenbrook Communications Limited

+44 20 7952 2000

Rob White / Michael Russell

 

Deutsche Numis (Financial Adviser & Broker)

+44 20 7260 1000

Nathan Brown / Matt Goss

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds2.

A video introduction to OCI is available at https://oakleycapitalinvestments.com/videos/

The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

The Oakley Funds

Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV, Oakley Capital V, Oakley Capital Origin Fund and Oakley Capital Origin II, are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Oakley family of funds also includes Oakley PROfounders Fund III and Oakley Touring Venture Fund, which are venture capital funds focused on investments in entrepreneur-led, disruptive, technology led companies.

For more information on the Oakley Fund strategies in which OCI invests, please click here.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHVLLFBELLEBBK
Date   Source Headline
8th Mar 20139:32 amRNSHolding(s) in Company
1st Feb 20137:00 amRNSCompletion of Sale of Emesa
4th Jan 20132:16 pmRNSHolding(s) in Company
24th Dec 201210:23 amRNSDisposal of Emesa Group Holdings B.V - Replacement
24th Dec 20127:00 amRNSDisposal of Emesa Group Holdings B.V
11th Sep 20127:00 amRNSHalf Yearly Report
10th Jul 20129:52 amRNSPreliminary Statement of unaudited NAV
6th Jul 20127:00 amRNSPurchase of Shares
5th Jul 201211:21 amRNSPurchase of Shares
3rd Jul 20127:00 amRNSPurchase of Shares
26th Jun 20127:00 amRNSDirector/PDMR Shareholding
30th Apr 20123:40 pmRNSHolding(s) in Company
24th Apr 20127:00 amRNSFinal Results
8th Feb 20124:40 pmRNSHolding(s) in Company
31st Jan 20127:00 amRNSTrading Update
23rd Nov 20117:00 amRNSInvestment in intergenia
22nd Sep 20115:01 pmRNSDirector/PDMR Shareholding
16th Aug 20117:00 amRNSHalf Yearly Report
5th Jul 20117:00 amRNSPre-close Statement
17th Jun 20114:51 pmRNSResult of AGM
27th May 20117:00 amRNSInvestment
19th Apr 20117:00 amRNSPreliminary results
25th Mar 20117:00 amRNSInvestment in Emesa B.V.
18th Jan 20117:00 amRNSTrading Update
17th Jan 20113:51 pmRNSStatement re press speculation
25th Nov 20107:00 amRNSInvestment in Time Out
4th Nov 20107:00 amRNSAcquisition of BDO Investment Management
29th Oct 20107:00 amRNSCompletion of disposal of Host Europe for £222m
13th Oct 20105:39 pmRNSNotification of major interest in shares
29th Sep 20105:02 pmRNSNotification of major interest in shares
16th Sep 20105:25 pmRNSNotification of major interest in shares
15th Sep 20107:00 amRNSIncrease in estimated NAV per share
15th Sep 20107:00 amRNSDisposal of Host Europe
17th Aug 20107:00 amRNSInterim Results
16th Aug 20105:22 pmRNSNotification of major interest in shares
3rd Aug 20108:00 amRNSKey management appointment
3rd Aug 20107:00 amRNSFinal Date for Warrant Exercise
6th Jul 20107:00 amRNSTrading Update
23rd Jun 20104:52 pmRNSResults of AGM
17th Jun 20107:00 amRNSAvailability of Annual Report
28th Apr 20107:00 amRNSPreliminary Results
22nd Apr 201010:44 amRNSNotice of Results
15th Apr 20105:13 pmRNSHolding(s) in Company
15th Apr 20105:06 pmRNSHolding(s) in Company
12th Apr 20104:23 pmRNSNotification of major interest in shares
10th Feb 201012:27 pmRNSNotification of Major Interest in Shares
25th Jan 20107:00 amRNSTrading Update
7th Dec 20097:00 amRNSAcquisition of 51% of Verivox Holdings Limited
19th Nov 200912:44 pmRNSNotification of Major Interest in Shares
11th Nov 200911:55 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.